ADARB1 and brain neoplasm: Transcript levels of I ‘writers’ ADAR, ADARB1, and ADARB2 are reduced in different grades and types of brain tumours [116]; ADAR2 was found to inhibit GBM cell growth, and an abnormally expressed splice variant supressed adenosine-to-inosine RNA editing [117,118].